Funding Opportunities

Winship researchers receive funding through a variety of awards and grants. View a selection of federal and private funding opportunities for which Winship researchers may be eligible to apply.

Rochfort Scholarship in Oncology

The Chester P. Rochfort Scholarship in Oncology is to assist young MD degree holders in cancer research.  The scholarship is $10,000 for one year and intended to help cover partial salary, laboratory or other research expenses or travel.  A discretionary account will be set up for the use of the recipient’s department.

Eligibility Criteria
To be eligible for this award mechanism, applicant must meet the following criteria:

  • Physician (M.D., M.D./Ph.D.) with enrollment within the Emory University School of Medicine or Rollins School of Public Health Fellowship Programs;
  • Awardee must be in an oncology field with career goals in the research and treatment/prevention of cancer.

Please email your completed application as a PDF to winshipgrants@emory.edu by 5pm Friday, March 31, 2017.

Application Deadline: Friday, March 31, 2017 at 5:00 PM

Anticipated Start: July 1, 2017

Elkin Fellowship in Oncology

The Nell W. and William S. Elkin Fellowship in Oncology is to be awarded to an extraordinary scientist and clinician with career goals in the research and treatment of cancer.  Scholarships are $35,000 for one-year and are intended to help cover partial salary, laboratory or other research expenses or travel. A discretionary account will be set up for the use by the recipient’s department.

Eligibility Criteria
To be eligible for this award mechanism, applicant must meet the following criteria:
  • Physician (M.D., M.D./Ph.D.) with enrollment within the Emory University School of Medicine or Rollins School of Public Health Fellowship Programs;
  • Awardee must be in an oncology field with career goals in the research and treatment/prevention of cancer.

Please email your completed application as a PDF to winshipgrants@emory.edu by 5pm Friday, March 31, 2017.

Application Deadline: March 31, 2017

Anticipated Start: July 1, 2017

Ovarian Cancer Research Consortium Grant

The Honorable Tina Brozman Foundation (“Tina’s Wish”) is requesting Letters of Intent for the Tina’s Wish Consortium Grant to bring together research institutions to collaborate and work together on the early detection and prevention of this disease. Annual costs for this three-year grant total $300,000, inclusive of indirect costs that should not exceed 10%.  

Eligibility
  • Applicants must be working in a school of medicine or public health, or a recognized non-profit scientific research facility in the U.S.
  • The research project for which support is requested should be innovative and not currently funded.
  • Applicants must have attained an academic position of Assistant Professor or higher (or equivalent).
  • Projects can be designed as one collaborative project or multiple related projects.
  • At least one part of the proposed project must be novel and not previously funded.
  • Applications must be from a minimum of three different research institutions and two of the PIs cannot have previously shared funding. There is no limit on the number of project PIs but one PI must be designated as the primary contact. 


Letter of Intent Deadline: April 3, 2017 at noon ET

Invitation to Submit Full Proposals: May 15, 2017

Full Proposal Deadline: July 1, 2017

Funding Start Date: January 2018

V Scholar Award

The V Foundation’s V Scholar Award supports tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. The total amount of the grant is $200,000 awarded in two annual installments of $100,000, each. Only direct costs of the research are supported by this award. Additionally, at least one of the highest ranked applications from a minority applicant will receive a 2017 Stuart Scott Memorial Fund V Scholar Award. Any area of cancer research is eligible.

Eligibility

  • Applicant must have at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for the specialty.
  • Hold a tenure-track faculty position as an assistant professor at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for this grant competition.
  • Have been appointed to their first full-time assistant professor position within the last 5 years, and not yet been promoted to Associate Professor.
  • Clinical scientists are eligible if the research institution can demonstrate that it will fully support the research applicant (e.g., dedicated lab space, start-up funds, dedicated research time).
  • Applicant must be either a US Citizen or be a permanent legal resident in the US.
  • Applicant cannot already have been awarded an R01, research project grant (RPG), or other R01-equivalent grant.

Letters of Intent
Letters of Intent (not to exceed 2 pages) are due April 14, 2017 via email to winshipgrants@emory.edu. Letters of Intent should also include the PI’s NIH Biosketch, a proposed title for the research project, and a brief 1-2 page abstract of the proposed research project. The selected investigators will be notified by Winship and invited to submit a full application.

Letter of Intent Deadline: 5:00 PM EST on Friday, April 14, 2017
Announcement of Nominee Selection: Friday, April 28, 2017
V Scholar Application Due Date: 5:00 PM EST on Thursday, June 1, 2017
Contact: Jeff Mills (404) 727-3634, jeff.mills@emory.edu

NRG NCORP Cancer Prevention and Control Pilot Projects

NRG Oncology NCORP is soliciting pilot projects for applications focused on NRG NCORP Cancer Prevention and Control priorities that will provide data that will directly lead to future phase II-III Cancer Prevention and Control concepts. Priorities for funding are:

  • Cancer prevention research aimed at identifying and evaluating interventions to reduce the risk and incidence of cancer; priority will be given to concepts in women's health, and other concepts are welcome
  • Cancer control research aimed at reducing the incidence and co-morbidity of cancer and its treatment focused on the four symptomatic management themes: neurotoxicity, cardiotoxicity, lymphedema, and inflammation (including cancer-related fatigue)
  • Survivorship and palliative care interventions aimed at reducing toxicity and symptom burden, and improving quality of life
  • Cancer disparity research, in collaboration with NRG Oncology's Health Disparities Research Program, focused on efforts to increase the participation of minorities and underserved populations in Cancer Prevention and Control studies

Integral to these priorities is the establishment of biospecimen repositories for molecular studies. Funding can be requested for up to $18,000 and is contingent upon NRG Oncology’s receipt of the Notice of Award from the Division of Cancer Prevention. One to two projects may be funded. Projects are to be completed by December 31, 2018.

Eligibility
Applicant must be an NRG Oncology member.

Instructions for Applicants
Please submit a proposal (max 5 pages) to fielde@nrgoncology.org by 5pm ET, Friday, May 5, 2017. The application must include:

  • Description of project, including summary of specific aims
  • How the project will help lead to a Phase II or Phase III NCORP concept
  • Are NRG Oncology resources required? (i.e., biospecimen materials, statistical support, etc.)
  • Investigators who will participate in project
  • Timeline [not included in the 5-page limit]
  • NIH biosketch of PI [not included in the 5-page limit]
  • Detailed budget [not included in the 5-page limit]

Application Deadline: Friday, May 5, 2017 at 5:00 PM ET

Submit Applications To:
Erica Field, MPH, MHA, CCRP, fielde@nrgoncology.org
(215) 940-8824

Direct Scientific Questions to NRG NCORP Co-Chairs:
Deborah Watkins Bruner, RN, PhD, FAAN, deborah.w.bruner@emory.edu
Larry Wickerham, MD, wickerhamd@nrgoncology.org
Joan Walker, MD, Joan-walker@ouhsc.edu

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery

The Behavioral Research Program, Epidemiology and Genomics Research Program, and Healthcare Delivery Research Program of the National Cancer Institute’s Division of Cancer Control and Population Sciences have collaborated on the release of a program announcement to study the utilization, adherence, and delivery of oral anticancer agents.  Specifically, this program announcement encourages research grant applications to:

  1. Assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; 
  2. Identify structural, systemic, and psychosocial barriers to adherence; and 
  3. Develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.   

PA-17-060 (R01)
PA-17-061 (R21)

Standard application due dates apply.

Cascade Link  TOP